EPAS1 and neoplasm: Sections were stained with antibodies to HIF-2α, eNOS, or β4 integrin (Figure 1A and Figure 2A), and the pathologist evaluated the quantitative assessment of scoring data in tumor tissues and adjacent normal areas.